<DOC>
	<DOCNO>NCT01182389</DOCNO>
	<brief_summary>Ventricular tachycardia ( VT ) abnormal rapid heartbeat occur heart attack cause sudden death . Patients risk rhythm disturbance usually receive implantable cardioverter defibrillator ( ICD ) prevent death return heart 's rhythm back normal electrically stimulate heart give patient painful debilitate shock . The first ICD shock implantation appear powerful predictor subsequent shock therapy well predictor increase mortality patient primary prevention ICDs . In patient receive repeat shock VT ablation perform 'burn ' abnormal area heart cause problem . However , often perform last resort technically challenge . We believe perform VT ablation use robotic system early first episode VT ICD implantation , may reduce number painful shock receive patient possibly increase life expectancy quality life . 200 patient 5 european country recruit prospective , open , randomised trial . Eligible , consent patient experience first episode VT since ICD implantation , randomise 1:1 manner treatment arm either VT ablation standard 'conventional ' therapy followed-up every 4 month two year ass number subsequent ICD shock , hospitalisation , mortality quality life .</brief_summary>
	<brief_title>A Study Early Robotic Ablation Substrate Elimination Ventricular Tachycardia</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Males female eighteen ( 18 ) eightyfive ( 85 ) year old ICD implantation postinfarct primary secondary prophylaxis First episode VT detect ( within monitor zone therapy ( ATP /shock deliver ) 12 lead ECG rate detection level device . Suitable candidate catheter ablation Signed informed consent Contraindication catheter ablation Ventricular tachycardia due transient , reversible cause Presence leave ventricular thrombus Severe cerebrovascular disease Active gastrointestinal bleeding Renal failure ( dialysis risk require dialysis ) Active infection fever Life expectancy short duration trial Allergy contrast Intractable heart failure ( NYHA Class IV ) Bleeding clot disorder inability receive heparin Serum [ K+ ] &lt; 3.5 &gt; 5.0mmol/L Serum Creatinine &gt; 200umol/L Uncontrolled diabetes ( HbA1c ≥73mmol/mol HbA1c ≤64mmol/mol Fasting Blood Glucose ≥9.2mmol/L ) Malignancy need therapy Pregnancy woman childbearing potential use highly effective method contraception Unable give inform consent Unable attend followup ICD clinic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Ventricular Tachycardia</keyword>
	<keyword>Implantable Cardioverter Defibrillator</keyword>
	<keyword>Catheter Ablation</keyword>
	<keyword>Robotic</keyword>
</DOC>